{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:35:49Z","timestamp":1791855349114,"version":"4.3.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/coc.0000000000000009","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T04:08:08Z","timestamp":1389154088000},"page":"8-12","source":"Crossref","is-referenced-by-count":51,"title":["Intensity-modulated Radiation Therapy for Anal Cancer"],"prefix":"10.1097","volume":"39","author":[{"given":"Jason A.","family":"Call","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M.","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay G.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine B.","family":"Ord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rojymon","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren K.","family":"Mell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210128","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.","volume":"348","author":"UKCCCR Anal Cancer Trial Working","year":"1996","journal-title":"Lancet"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":". Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"R3-2-20210128","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","article-title":". Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"R4-2-20210128","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":". Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"R5-2-20210128","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ijrobp.2009.07.038","article-title":". Radiation Therapy Oncology Group. A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal.","volume":"75","author":"Kachnic","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-2-20210128","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.ijrobp.2010.07.162","article-title":". Early efficacy results of RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.","volume":"78","author":"Kachnic","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-2-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","article-title":". Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.","volume":"82","author":"Kachnic","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-2-20210128","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2005.02.030","article-title":". Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.","volume":"63","author":"Milano","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-2-20210128","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ijrobp.2009.09.046","article-title":". Intensity-modulate radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.","volume":"78","author":"Pepek","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","article-title":". Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.","volume":"25","author":"Salama","year":"2007","journal-title":"J Clin Oncol"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.prro.2012.02.005","article-title":". Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: a retrospective review from a large academic center.","volume":"3","author":"Call","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"R13-2-20210128","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","article-title":". Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.","volume":"117","author":"Bazan","year":"2011","journal-title":"Cancer"},{"key":"R14-2-20210128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1200\/jco.2009.27.15_suppl.lba4009","article-title":". A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin5FU in squamous cell carcinoma of the anus (ACT II).","volume":"27","author":"James","year":"2009","journal-title":"J Clin Oncol"},{"key":"R15-2-20210128","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1016\/j.ijrobp.2006.07.525","article-title":". Dosimetric predictors of acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity modulated radiation therapy (IMRT).","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-2-20210128","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":". Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.","volume":"70","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-2-20210128","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0360-3016(02)03801-4","article-title":". Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.","volume":"54","author":"Brixey","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:57:47Z","timestamp":1620935867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201602000-00002"}},"subtitle":["Results From a Multi-Institutional Retrospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718233194.793550963","asserted-by":"object"}]},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}